IRIDEX CORP
Develops laser-based medical systems for ophthalmologists treating serious eye diseases.
IRIX | US
Overview
Corporate Details
- ISIN(s):
- US4626841013
- LEI:
- Country:
- United States of America
- Address:
- 1212 TERRA BELLA AVE, 94043 MOUNTAIN VIEW
- Website:
- https://www.iridex.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
IRIDEX Corporation is a global leader in developing, manufacturing, and marketing innovative laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Founded in 1989, the company provides versatile solutions for treating serious eye conditions, including glaucoma, diabetic macular edema, and other retinal diseases. A key offering is its proprietary MicroPulse® technology, a tissue-sparing laser therapy designed to provide effective treatment while minimizing collateral tissue damage. IRIDEX's product portfolio, which includes the PASCAL® and Cyclo G6® laser systems, serves ophthalmologists and surgeons in hospitals, ambulatory surgical centers, and office-based practices globally, aiming to advance the standard of patient care in eyecare.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IRIDEX CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IRIDEX CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IRIDEX CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||